BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 22172563)

  • 1. Characterization of the heterotrophic biomass and the endogenous residue of activated sludge.
    Ramdani A; Dold P; Gadbois A; Déléris S; Houweling D; Comeau Y
    Water Res; 2012 Mar; 46(3):653-68. PubMed ID: 22172563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradation of the endogenous residue of activated sludge.
    Ramdani A; Dold P; Déléris S; Lamarre D; Gadbois A; Comeau Y
    Water Res; 2010 Apr; 44(7):2179-88. PubMed ID: 20074768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradation of the endogenous residue of activated sludge in a membrane bioreactor with continuous or on-off aeration.
    Ramdani A; Dold P; Gadbois A; Déléris S; Houweling D; Comeau Y
    Water Res; 2012 Jun; 46(9):2837-50. PubMed ID: 22475080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upflow anaerobic sludge blanket reactor--a review.
    Bal AS; Dhagat NN
    Indian J Environ Health; 2001 Apr; 43(2):1-82. PubMed ID: 12397675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calibrating a side-stream membrane bioreactor using Activated Sludge Model No. 1.
    Jiang T; Liu X; Kennedy MD; Schippers JC; Vanrolleghem PA
    Water Sci Technol; 2005; 52(10-11):359-67. PubMed ID: 16459810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane bioreactor operation at short solids retention times: performance and biomass characteristics.
    Ng HY; Hermanowicz SW
    Water Res; 2005 Mar; 39(6):981-92. PubMed ID: 15766953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between EPS adherence, viscoelastic properties, and MBR operation: Biofouling study with QCM-D.
    Sweity A; Ying W; Ali-Shtayeh MS; Yang F; Bick A; Oron G; Herzberg M
    Water Res; 2011 Dec; 45(19):6430-40. PubMed ID: 22014563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active heterotrophic biomass and sludge retention time (SRT) as determining factors for biodegradation kinetics of pharmaceuticals in activated sludge.
    Majewsky M; Gallé T; Yargeau V; Fischer K
    Bioresour Technol; 2011 Aug; 102(16):7415-21. PubMed ID: 21652206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence, source, and fate of dissolved organic matter (DOM) in a pilot-scale membrane bioreactor.
    Meng F; Drews A; Mehrez R; Iversen V; Ernst M; Yang F; Jekel M; Kraume M
    Environ Sci Technol; 2009 Dec; 43(23):8821-6. PubMed ID: 19943652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling the biological performance of a side-stream membrane bioreactor using ASM1.
    Tian KJ; Liu XA; Jiang T; Kennedy MD; Schippers JC; Vanrolleghem PA
    J Environ Sci (China); 2004; 16(6):1020-3. PubMed ID: 15900742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of the unbiodegradable particulate fraction (XU) from different activated sludges during batch digestion tests at ambient temperature.
    Habermacher J; Benetti AD; Derlon N; Morgenroth E
    Water Res; 2016 Jul; 98():206-14. PubMed ID: 27107138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of membrane bioreactor configurations on sludge structure and microbial activity.
    Clouzot L; Roche N; Marrot B
    Bioresour Technol; 2011 Jan; 102(2):975-81. PubMed ID: 20947340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of sludge structure and activity in submerged membrane bioreactor.
    Spérandio M; Masse A; Espinosa-Bouchot MC; Cabassud C
    Water Sci Technol; 2005; 52(10-11):401-8. PubMed ID: 16459815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Process efficiency and microbial monitoring in MBR (membrane bioreactor) and CASP (conventional activated sludge process) treatment of tannery wastewater.
    Munz G; Gualtiero M; Salvadori L; Claudia B; Claudio L
    Bioresour Technol; 2008 Dec; 99(18):8559-64. PubMed ID: 18499451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative performance between intermittently cyclic activated sludge-membrane bioreactor and anoxic/aerobic-membrane bioreactor.
    Wang YL; Yu SL; Shi WX; Bao RL; Zhao Q; Zuo XT
    Bioresour Technol; 2009 Sep; 100(17):3877-81. PubMed ID: 19362820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of EPS content in activated sludge at different sludge retention times with membrane fouling phenomena.
    Al-Halbouni D; Traber J; Lyko S; Wintgens T; Melin T; Tacke D; Janot A; Dott W; Hollender J
    Water Res; 2008 Mar; 42(6-7):1475-88. PubMed ID: 18023465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerobic stabilization of biological sludge characterized by an extremely low decay rate: modeling, identifiability analysis and parameter estimation.
    Martínez-García CG; Olguín MT; Fall C
    Bioresour Technol; 2014 Aug; 166():112-9. PubMed ID: 24907570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of sludge characteristics and PCR-DGGE based microbial diversity of nanofiltration and microfiltration membrane bioreactors.
    Choi JH; Lee SH; Fukushi K; Yamamoto K
    Chemosphere; 2007 Apr; 67(8):1543-50. PubMed ID: 17258282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of tannery wastewater and biomass in a membrane bioreactor using respirometric analysis.
    Munz G; Gori R; Cammilli L; Lubello C
    Bioresour Technol; 2008 Dec; 99(18):8612-8. PubMed ID: 18499445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
    Radjenović J; Petrović M; Barceló D
    Water Res; 2009 Feb; 43(3):831-41. PubMed ID: 19091371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.